Harnessing Bacterial Agents to Modulate the Tumor Microenvironment and Enhance Cancer Immunotherapy

被引:3
|
作者
Thomas, Christina James [1 ]
Delgado, Kaylee [1 ]
Sawant, Kamlesh [1 ]
Roy, Jacob [1 ]
Gupta, Udit [1 ]
Song, Carly Shaw [1 ]
Poojary, Rayansh [1 ]
de Figueiredo, Paul [2 ]
Song, Jianxun [1 ]
机构
[1] Texas A&M Univ, Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, MREB 2,Room 3344,8447 John Sharp Pkwy, Bryan, TX 77807 USA
[2] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA
关键词
cancer immunotherapy; tumor microenvironment; engineered bacteria; immunosuppression; immune checkpoint inhibitors; bacterial therapeutics; antitumor immunity; ATTENUATED SALMONELLA-TYPHIMURIUM; METASTATIC BREAST-CANCER; ACTIVATION GENE-3 LAG-3; T-CELL DIFFERENTIATION; CLOSTRIDIUM-NOVYI-NT; SUPPRESSOR-CELLS; BACTERIOLYTIC THERAPY; DENDRITIC CELLS; IN-VITRO; HPV E7;
D O I
10.3390/cancers16223810
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer immunotherapy has revolutionized cancer treatment by leveraging the immune system to attack tumors. However, its effectiveness is often hindered by the immunosuppressive tumor microenvironment (TME), where a complex interplay of tumor, stromal, and immune cells undermines antitumor responses and allows tumors to evade immune detection. This review explores innovative strategies to modify the TME and enhance immunotherapy outcomes, focusing on the therapeutic potential of engineered bacteria. These bacteria exploit the unique characteristics of the TME, such as abnormal vasculature and immune suppression, to selectively accumulate in tumors. Genetically modified bacteria can deliver therapeutic agents, including immune checkpoint inhibitors and cytokines, directly to tumor sites. This review highlights how bacterial therapeutics can target critical immune cells within the TME, such as myeloid-derived suppressor cells and tumor-associated macrophages, thereby promoting antitumor immunity. The combination of bacterial therapies with immune checkpoint inhibitors or adoptive cell transfer presents a promising strategy to counteract immune suppression. Continued research in this area could position bacterial agents as a powerful new modality to reshape the TME and enhance the efficacy of cancer immunotherapy, particularly for tumors resistant to conventional treatments.
引用
收藏
页数:24
相关论文
共 50 条
  • [1] Utilizing precision medicine to modulate the prostate tumor microenvironment and enhance immunotherapy
    Olson, Brian
    Patnaik, Akash
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (08) : 535 - 542
  • [2] Targeting the tumor microenvironment to enhance immunotherapy against cancer
    Slaney, Clare Y.
    Oliver, Amanda J.
    Kershaw, Michael H.
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [3] Deconvoluting the tumor microenvironment to enhance immunotherapy
    Pollard, Jeffrey W.
    CANCER RESEARCH, 2021, 81 (05)
  • [4] Harnessing the Microbiome to Enhance Cancer Immunotherapy
    Nelson, Michelle H.
    Diven, Marshall A.
    Huff, Logan W.
    Paulos, Chrystal M.
    JOURNAL OF IMMUNOLOGY RESEARCH, 2015, 2015
  • [5] Reprogramming the tumor microenvironment with losartan to enhance immunotherapy of ovarian cancer.
    Sun, Yao
    Zhao, Wenjianlong
    Spriggs, David R.
    Jain, Rakesh K.
    Xu, Lei
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 32 - 33
  • [7] Modulating the tumor microenvironment to enhance cancer immunotherapy by inducing phosphatidylserine expression on the tumor surface
    Kaneko, Kensuke
    Osada, Takuya
    Freimark, Bruce D.
    Lyerly, Herbert Kim
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [8] Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy
    Yang, Jingxing
    Zhang, Chunfu
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2020, 12 (04)
  • [9] Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy
    Yu Huang
    Hui Fan
    Huihui Ti
    AsianJournalofPharmaceuticalSciences, 2024, 19 (02) : 3 - 39
  • [10] Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy
    Huang, Yu
    Fan, Hui
    Ti, Huihui
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 19 (02)